Mvm Partners, Llc Sells 4,256 Shares of Paragon 28, Inc. (NYSE:FNA) Stock

Paragon 28, Inc. (NYSE:FNA) major shareholder Mvm Partners, Llc sold 4,256 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $10.00, for a total transaction of $42,560.00. Following the completion of the sale, the insider now owns 10,499,960 shares in the company, valued at $104,999,600. This represents a 0.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Mvm Partners, Llc also recently made the following trade(s):

• On Monday, November 25th, Mvm Partners, Llc sold 10,835 shares of Paragon 28 stock. The shares were sold at an average price of $10.09, for a total transaction of $109,325.15.
• On Friday, November 22nd, Mvm Partners, Llc sold 72,133 shares of Paragon 28 stock. The stock was sold at an average price of $10.16, for a total value of $732,871.28.
• On Wednesday, November 20th, Mvm Partners, Llc sold 147,581 shares of Paragon 28 stock. The stock was sold at an average price of $10.28, for a total value of $1,517,132.68.

Paragon 28 Stock Performance

Shares of NYSE FNA opened at $10.31 on Friday. The stock’s 50-day moving average is $7.02 and its 200 day moving average is $7.29. The stock has a market cap of $863.15 million, a price-to-earnings ratio of -13.93 and a beta of 1.01. Paragon 28, Inc. has a 1-year low of $4.65 and a 1-year high of $14.79. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79.

Paragon 28 (NYSE:FNA) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.16) by $0.01. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The firm had revenue of $62.30 million for the quarter, compared to the consensus estimate of $60.58 million. During the same period last year, the firm posted ($0.10) earnings per share. The business’s revenue was up 18.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Paragon 28, Inc. will post -0.66 EPS for the current fiscal year.

Institutional Trading of Paragon 28

Several hedge funds have recently added to or reduced their stakes in the business. Nisa Investment Advisors LLC increased its holdings in shares of Paragon 28 by 46,660.0% in the second quarter. Nisa Investment Advisors LLC now owns 4,676 shares of the company’s stock worth $32,000 after buying an additional 4,666 shares during the period. Levin Capital Strategies L.P. purchased a new position in Paragon 28 in the 2nd quarter worth approximately $68,000. Intech Investment Management LLC bought a new stake in Paragon 28 in the third quarter valued at approximately $70,000. Price T Rowe Associates Inc. MD boosted its stake in shares of Paragon 28 by 16.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,622 shares of the company’s stock valued at $156,000 after purchasing an additional 1,766 shares during the period. Finally, Ballentine Partners LLC bought a new position in shares of Paragon 28 in the third quarter worth approximately $91,000. 63.57% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on FNA shares. Canaccord Genuity Group cut their price objective on Paragon 28 from $17.00 to $15.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Needham & Company LLC boosted their price target on shares of Paragon 28 from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Finally, Piper Sandler reissued an “overweight” rating and issued a $12.00 price target (down previously from $15.00) on shares of Paragon 28 in a report on Friday, August 9th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $15.60.

About Paragon 28

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.